Hepion's CRV431 Shows Encouraging Safety Profile In Drug-Drug Interaction Study
September 29, 2021 at 12:20 PM EDT
Hepion Pharmaceuticals Inc(NASDAQ: HEPA) hasannounced results from a Drug-Drug Interaction (DDI) studywith its lead ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.